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1 |  INTRODUCTION
Compared to other sensory‐perceptual functions and unlike 
some neurodegenerative disorders, olfactory function in ep-
ilepsy has not been thoroughly studied. Some studies have 
linked temporal lobe epilepsy with olfactory dysfunction, 
and their results show a variable impairment in olfactory 
threshold, odor identification, and odor discrimination.1‒4 
These olfactory functions depend mainly on the primary 
olfactory regions, which include the piriform cortex, the ol-
factory bulb, the anterior olfactory nucleus, the olfactory tu-
bercle, the periamygdaloid cortex, and the anterior part of the 
entorhinal cortex.5,6 Beyond these regions, the olfactory net-
work includes the orbitofrontal cortex, the thalamus, and the 
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Abstract
Several lines of research have linked olfactory regions with the pathophysiology of 
focal epilepsies. Among those regions, the piriform cortex represents the major part 
of the primary olfactory cortex. According to these data, we raised the hypothesis that 
in patients with mesial temporal lobe epilepsy associated with hippocampal sclerosis 
exists an interictal dysfunction of olfactory processing that could be more significant 
compared to patients with extra‐hippocampal focal epilepsy and healthy controls. 
This could be the consequence of a dysfunctional epileptogenic network that extends 
beyond the hippocampus and affects other structures, including the piriform cortex. 
To test this hypothesis, we evaluated the olfactory function with the Sniffin' Sticks 
test in 32 patients with mesial temporal lobe epilepsy associated with hippocampal 
sclerosis, 30 patients with extra‐hippocampal focal epilepsy, and 22 healthy con-
trols. Compared to the other study groups, patients with temporal lobe epilepsy due 
to hippocampal sclerosis showed a basal olfactory dysfunction characterized by an 
impairment in odor discrimination and odor identification. We also found that high 
seizure frequency had a strong correlation with the evaluated olfactory tasks. Our 
results are consistent with neuroimaging and neuropathological data that establish a 
link between olfactory regions and the pathophysiology of temporal lobe epilepsy.
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insula.5,6 All of these structures may be affected in temporal 
lobe epilepsy and could explain the interictal olfactory dys-
function. However, the piriform cortex remains the most im-
portant region related to olfactory processing and represents 
the major part of the primary olfactory cortex.6,7
As well as the hippocampus, the piriform cortex has a 
three‐layered allocortical structure, is vulnerable to cell dys-
function induced by excitotoxicity, and is highly susceptible 
to secondary epileptogenesis induced by electrical and chem-
ical stimulus.8,9 The piriform cortex is located at the junction 
of the temporal and frontal lobes.10 The temporal aspect of the 
piriform cortex is related to the amygdala and the entorhinal 
cortex, the frontal aspect is related to the olfactory tubercle 
and the olfactory tract, and the lateral aspect merges into the 
insula.9,10 The strategic anatomical location of the piriform 
cortex allows it to be a common pathway for the propagation 
of epileptiform discharges in focal epilepsies.11 This is in line 
with some neuroimaging studies that have shown that in pa-
tients with mesial temporal lobe epilepsy, the dysfunction of 
anatomical circuits goes beyond the hippocampus and affects 
other structures such as the piriform cortex.12
According to these data, we raised the hypothesis that in 
patients with mesial temporal lobe epilepsy associated with 
hippocampal sclerosis, there could exist an interictal olfac-
tory dysfunction, which could be more significant compared 
to patients with extra‐hippocampal focal epilepsy and healthy 
controls. To test this hypothesis, we evaluated the olfactory 
function with the Sniffin' Sticks test in the three study groups 
previously mentioned.
2 |  MATERIALS AND METHODS
2.1 | Patients and study design
A comparative case series study with consecutive sampling 
was performed. We recruited patients aged 18‐65 years who 
had an epilepsy diagnosis and were treated at the epilepsy 
units of Hospital Ruber Internacional, Hospital Ramon y 
Cajal, or Hospital Clinico San Carlos, in Madrid, Spain. The 
patients were classified into two study groups: patients with 
mesial temporal lobe epilepsy associated with hippocampal 
sclerosis and patients with extra‐hippocampal focal epilepsy. 
In addition, we recruited a third group of healthy controls 
among the relatives of the patients that were age‐ and sex‐
matched. We excluded subjects with a history of smoking, 
physical and/or mental limitations, epilepsy surgery, seizures 
in the previous week to evaluation, traumatic brain injury, 
neurodegenerative disorders associated with olfactory dys-
function, upper respiratory infection in the previous week 
to evaluation, allergic rhinitis, and diseases of the paranasal 
sinuses. Patients with dual pathology or extensive lesions 
on MRI were also excluded. The etiology and classifica-
tion of each group was based on clinical history, semiology, 
video‐EEG, and brain MRI. To evaluate the olfaction, the ex-
tended version of the Sniffin' Sticks test (n‐Butanol version) 
was applied. This is a validated and commonly used tool 
for assessment of olfactory function in subjects with normal 
sense of smell and in individuals with smell loss.13 Compared 
with other tests, the Sniffin' Sticks test explores three differ-
ent components of olfaction: odor perception threshold, odor 
discrimination, and odor identification. Each olfactory func-
tion can be evaluated separately, and the sum of these three 
components corresponds to a global TDI score.
2.2 | Case definition
• Mesial temporal lobe epilepsy associated with hippocam-
pal sclerosis (HS): patients with focal epilepsy in whom 
seizure semiology suggests a mesial temporal lobe onset 
and is associated with hippocampal atrophy and abnormal-
ities of the hippocampal signal intensity on MRI studies, as 
well as interictal/ictal epileptiform activity located at the 
temporal lobe.
• Extra‐hippocampal focal epilepsy (EH): patients with 
focal epilepsy in whom seizure semiology does not sug-
gest a mesial temporal lobe onset and is associated with an 
extra‐hippocampal lesion on MRI studies, as well as inter-
ictal/ictal epileptiform activity congruent with that lesion, 
and normal hippocampus on brain MRI.
• Healthy control (HC): healthy subjects aged 18‐65 years 
who do not meet any of the exclusion criteria.
2.3 | Statistical analysis
The data were analyzed with the R software (version 3.2.1) 
using the packages epicalc, robust, and relaimpo.14 A descrip-
tion of each variable, based on the median and interquartile 
range for quantitative variables and absolute and relative fre-
quency for categorical variables, was made. The association 
between the study group (HS, EH, and HC) and the clinical 
and demographic variables was assessed with one‐way analy-
sis of variance, the Pearson chi‐square test, or the Fisher exact 
test, as appropriate. The association between the study group 
and the olfactory variables was evaluated with both crude 
and adjusted tests. Given the data distribution, crude analyses 
were performed with the Kruskal‐Wallis test, and adjusted 
analyses were performed with robust multiple linear regres-
sion. The adjustment variables were age, sex, seizure fre-
quency, and duration of disease. Due to high collinearity, the 
number of antiepileptic drugs and the laterality of the lesion 
were excluded from the models. Post hoc analyses were per-
formed with the Tukey HSD (honestly significant difference) 
test. In all cases, we applied bilateral tests and considered 
significant P values less than 0.05. Finally, we also investi-
gated the relative importance of the study group and other 
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clinical variables on their ability to predict the TDI score. To 
this end, we calculated the lmg values of each variable with 
the relaimpo package. The lmg value indicates the portion of 
the total variability of the dependent variable explained by the 
model corresponding to each of the predictor variables.
3 |  RESULTS
Eighty‐four participants were included. Thirty‐two patients 
were in the group of HS, 30 were in the group of EH, and 22 
were HC. Table 1 summarizes the demographic and clinical 
variables of the three groups. The crude and adjusted tests 
of association between the study group and the olfactory 
variables are shown in Table 2 and Figure S1. In the crude 
analyses, we found a significant association with all olfac-
tory variables. However, after adjusting by age, sex, seizure 
frequency, and duration of disease, only odor discrimination 
(P < 0.001), odor identification (P < 0.001), and TDI score 
(P < 0.001) remained statistically significant. In the post hoc 
analyses, we found that patients with HS showed a statistical 
difference in the three olfaction tests as compared with pa-
tients with EH and HC. In the adjusted analyses, in addition 
to study group, we also found that high seizure frequency 
T A B L E  1  Demographic and clinical variables.
  Hippocampal epilepsy Extra‐hippocampal epilepsy Healthy controls Test P value
Total 32 30 22 – –
Age, median (IQR) 44.5 (37.5‐52) 32.5 (25‐46) 42.5 (34.5‐46) ANOVA 0.004
Duration of disease, median 
(IQR)
28.5 (15.8‐38.2) 13.5 (10‐22.8) ‐ t test 0.001
Sex frequency (percentage)
Female 14 (43.8) 12 (40) 11 (50) Chi‐square test 0.772
Male 18 (56.2) 18 (60) 11 (50)
Type of seizures, frequency (percentage)
Focal without impair-
ment of consciousness
8 (25) 17 (56.7) ‐ Fisher's exact 
test
0.019
Focal with impairment of 
consciousness
23 (71.9) 13 (43.3)
Generalized 1 (3.1) 0 (0)
History of status epilepticus, frequency (percentage)
Yes 1 (3.1) 5 (16.7) ‐ Fisher's exact 
test
0.099
No 31 (96.9) 25 (83.3)
Febrile seizures, frequency (percentage)
Yes 8 (25) 0 (0) ‐ Fisher's exact 
test
0.005
No 24 (75) 30 (100)
Seizure frequency in the last year, frequency (percentage)
No seizures (6.2) 4 (13.3) ‐ Fisher's exact 
test
0.88
1‐3 7 (21.9) 4 (13.3)
4‐6 4 (12.5) 4 (13.3)
7‐9 2 (6.2) 2 (6.7)
≥10 17 (53.1) 16 (53.3)
Laterality of the lesion, frequency (percentage)
Left 19 (59.4) 19 (63.3) ‐ Fisher's exact 
test
0.99
Right 11 (34.4) 10 (33.3)
Bilateral 2 (6.2) 1 (3.3)
Number of antiepileptic drugs, frequency (percentage)
1 4 (12.5) 8 (26.7) ‐ Fisher's exact 
test
0.008
2 18 (56.2) 10 (33.3)
3 5 (15.6) 12 (40)
≥4 5 (15.6) 0 (0)
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(≥10 in the last year) showed a strong statistical association 
with odor discrimination (P  <  0.001), odor identification 
(P  =  0.0011), and TDI score (P  <  0.001). Concerning the 
relative importance of the clinical variables on their abil-
ity to predict the TDI score, the variables with the highest 
lmg values were seizure frequency (0.284) and study group 
(0.277), followed by duration of disease (0.036), history of 
febrile seizures (0.025), and history of status epilepticus in 
the last 5 years (0.018). The proportion of the total variance 
explained by the model was 67%.
4 |  DISCUSSION
Compared to patients with extra‐hippocampal focal epilepsy 
and healthy controls, patients with HS show an interictal ol-
factory dysfunction characterized by an impairment in odor 
discrimination, odor identification, and TDI score. As we 
mentioned before, these olfactory functions depend on sev-
eral frontal, temporal, and limbic anatomical structures. In 
particular, the entorhinal cortex is involved in odor identifica-
tion and memory tasks,15 the orbitofrontal cortex is involved 
in the odor identity and offers a multisensory integration of 
olfaction,16 the amygdala is involved in the emotional aspect 
of olfaction, and the inferior frontal gyrus is important for 
naming odors.17‒19 Another important region is the olfactory 
bulb, since it represents one of the first anatomical structures 
of olfactory processing and has a unique morphological con-
figuration that exhibits a strong connectivity with a high num-
ber of synapses that can only be compared with the cerebellar 
cortex or the hippocampus.19,20 In addition, the olfactory bulb 
serves as the main afferent to mesial temporal structures and 
is involved not only in the olfactory processing, but also in 
the pathophysiology of some temporal lobe epilepsies.18‒20
All the structures mentioned above may be part of the 
epileptogenic network in HS12 and could explain the inter-
ictal olfactory dysfunction that we have found; however, the 
piriform cortex remains the most important region related 
to olfactory processing and represents the major part of the 
primary olfactory cortex.6,7 Besides that, it has a strong con-
nectivity with anatomical structures involved in the epilepto-
genic network of HS, and its activation has been documented 
in all olfactory tasks, mainly in odor discrimination and ol-
factory working memory tasks.21,22 This is consistent with 
some imaging and neuropathological studies that have shown 
that the piriform cortex seems to be an important modula-
tor in the pathophysiology of temporal lobe epilepsy.11,23‒25 
In this regard, an EEG‐fMRI study conducted by Fahoum et 
al showed that patients with temporal lobe epilepsy had an 
ipsilateral activation of the piriform cortex, the insula, the 
claustrum, and the amygdala.25 Flanagan et al found simi-
lar results, supporting the idea that the piriform cortex is a 
T
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common pathway for the propagation of epileptiform dis-
charges in focal epilepsies.11
Our findings further support the hypothesis that the olfac-
tory dysfunction observed in the group of patients with HS 
is the consequence of a dysfunctional epileptogenic network 
that extends through the piriform cortex and nearby struc-
tures. In the same line, a recent publication by Galovic et al 
revealed the importance of the resection of the piriform cor-
tex in the postoperative seizure outcome of patients with tem-
poral lobe epilepsy.26 They found that the removal of at least 
half of the piriform cortex increases the odds of becoming 
seizure‐free by a factor of 16 (95% CI, 5‐47).26
In our series, we also found that high seizure frequency 
had a strong correlation with the evaluated olfactory tasks. 
This finding is consistent with some animal and neuroimag-
ing studies that have shown that the piriform cortex is highly 
susceptible to electrical kindling.8,27 In the same line, Laufs 
et al evaluated two separate groups of patients with focal epi-
lepsies using either simultaneous EEG‐fMRI or [11C]fluma-
zenil PET.28 They found that GABAa receptor binding near 
the frontal piriform cortex ipsilateral to the presumed cortical 
focus was reduced in patients with more frequent seizures.28 
These data suggest that altered GABAergic inhibition in the 
piriform cortex may be a consequence of increased seizure 
frequency, which is congruent with our results showing 
that patients with high seizure frequency have a tendency 
to exhibit a lower performance in odor discrimination, odor 
identification, and TDI score. We are aware of several meth-
odological limitations of our study, including a lack of re-
peated testing, a relatively small sample size, and a lack of 
pathological confirmation. In addition, this study was based 
on a medical record of consecutive patients, which limits its 
direct application to the general population. However, our 
findings are consistent with several studies that have found 
similar results,1‒4 and are congruent with previous neuro-
imaging and neuropathological data showing an association 
between olfactory regions and the pathophysiology of tem-
poral lobe epilepsy. The selective involvement of olfactory 
functions in patients with HS raises the possibility of using 
unified olfactory tests in the noninvasive evaluation of these 
subjects.
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